UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 476

Sortiert nach

Sodium-Glucose Co-Transport Inhibitors: Progress and Therapeutic Potential in Type 2 Diabetes Mellitus

Drugs (New York, N.Y.), 2010-03, Vol.70 (4), p.377-385

2010

Volltextzugriff (PDF)

Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis

Clinical and translational science, 2019-01, Vol.12 (1), p.39-46

2019

Volltextzugriff (PDF)

Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition

Clinical diabetes, 2010-01, Vol.28 (1), p.5-10

White, John R.

2010

Volltextzugriff (PDF)

Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use

Clinical diabetes, 2008-04, Vol.26 (2), p.53-57

White, John R.

2008

Volltextzugriff (PDF)

A Brief History of the Development of Diabetes Medications

Diabetes spectrum, 2014-05, Vol.27 (2), p.82-86

White, Jr, John R

2014

Volltextzugriff (PDF)

Aspirin Therapy in Patients With Diabetes: An Update on Current Recommendations

Diabetes spectrum, 2013-08, Vol.26 (3), p.153-155

2013

Volltextzugriff (PDF)

Empagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes mellitus: a review of the evidence

The Annals of pharmacotherapy, 2015-05, Vol.49 (5), p.582

White, Jr, John R

2015

Volltextzugriff (PDF)

Sugar

Clinical diabetes, 2018-01, Vol.36 (1), p.74

White, Jr, John R

2018

Volltextzugriff (PDF)

New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus

The Annals of pharmacotherapy, 2015-10, Vol.49 (10), p.1153

2015

Volltextzugriff (PDF)

Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults

Clinical toxicology (Philadelphia, Pa.), 2016-04, Vol.54 (4), p.308-312

2016

Volltextzugriff (PDF)

Titratable fixed-ratio combinations in type 2 diabetes mellitus: focus on GLP-1R agonists combined with basal insulin

The Journal of family practice, 2017-04, Vol.66 (4), p.528

2017

Volltextzugriff (PDF)

Smartphone-Based Glucose Monitors and Applications in the Management of Diabetes: An Overview of 10 Salient “Apps” and a Novel Smartphone-Connected Blood Glucose Monitor

Clinical diabetes, 2012-10, Vol.30 (4), p.173-178

2012

Volltextzugriff (PDF)

Assessment of Regular and NPH Insulin Concentration via Two Methods of Quantification: The Washington State Insulin Concentration Study (WICS)

Journal of diabetes science and technology, 2021-03, Vol.15 (2), p.324-328

2021

Volltextzugriff (PDF)

Overview of Ertugliflozin

Clinical diabetes, 2019-04, Vol.37 (2), p.176-178

2019

Volltextzugriff (PDF)

From Randomized Controlled Trials to the Real World: Putting Evidence into Context

The Journal of family practice, 2018-08, Vol.67 (8 suppl), p.S55-S60

2018

Volltextzugriff (PDF)

Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes

Clinical diabetes, 2016-04, Vol.34 (2), p.86-91

White, Jr, John R

2016

Volltextzugriff (PDF)

Nasal Glucagon: A Promising New Way to Treat Severe Hypoglycemia

Clinical diabetes, 2019-07, Vol.37 (3), p.292-293

2019

Volltextzugriff (PDF)

Sodium Glucose Cotransporter 2 Inhibitors

The Medical clinics of North America, 2015-01, Vol.99 (1), p.131-143

White, John R., PA-C, PharmD

2015

Volltextzugriff (PDF)

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know

Clinical diabetes, 2018-04, Vol.36 (2), p.174-182

2018

Volltextzugriff (PDF)

Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization

Journal of managed care & specialty pharmacy, 2016-04, Vol.22 (4), p.381

2016

Volltextzugriff (PDF)

Novel insulins and strict glycemic control: Analogues approximate normal insulin secretory response

Postgraduate medicine, 2003-06, Vol.113 (6), p.30-36

2003

Volltextzugriff (PDF)

U-500 Insulin: Clinical Comments From the Experts

Clinical diabetes, 2013-03, Vol.31 (2), p.49-50

White, John R., Jr

2013

Volltextzugriff (PDF)

Association of Antidepressant Medication Therapy With Inpatient Rehabilitation Outcomes for Stroke, Traumatic Brain Injury, or Traumatic Spinal Cord Injury

Archives of physical medicine and rehabilitation, 2011-05, Vol.92 (5), p.683-695

2011

Volltextzugriff (PDF)

First-line pharmacologic treatment for type 2 diabetes: optimizing metformin therapy

Pharmacy times, 2010-06, Vol.76 (6)

White, Jr., John R

2010

Volltextzugriff (PDF)

Angiotensin Receptor Blocker to Prevent Microalbuminuria?

Clinical diabetes, 2012-01, Vol.30 (1), p.20-22

White, John R., Jr

2012

Volltextzugriff (PDF)

1 – 25 von 476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(418)
Mit Volltextzugriff
(396)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sodium-Glucose Co-Transport Inhibitors: Progress and Therapeutic Potential in Type 2 Diabetes Mellitus

Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis

Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition

Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use

A Brief History of the Development of Diabetes Medications

Aspirin Therapy in Patients With Diabetes: An Update on Current Recommendations

Empagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes mellitus: a review of the evidence

Sugar

New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus

Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults

Titratable fixed-ratio combinations in type 2 diabetes mellitus: focus on GLP-1R agonists combined with basal insulin

Smartphone-Based Glucose Monitors and Applications in the Management of Diabetes: An Overview of 10 Salient “Apps” and a Novel Smartphone-Connected Blood Glucose Monitor

Assessment of Regular and NPH Insulin Concentration via Two Methods of Quantification: The Washington State Insulin Concentration Study (WICS)

Overview of Ertugliflozin

From Randomized Controlled Trials to the Real World: Putting Evidence into Context

Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes

Nasal Glucagon: A Promising New Way to Treat Severe Hypoglycemia

Sodium Glucose Cotransporter 2 Inhibitors

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know

Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization

Novel insulins and strict glycemic control: Analogues approximate normal insulin secretory response

U-500 Insulin: Clinical Comments From the Experts

Association of Antidepressant Medication Therapy With Inpatient Rehabilitation Outcomes for Stroke, Traumatic Brain Injury, or Traumatic Spinal Cord Injury

First-line pharmacologic treatment for type 2 diabetes: optimizing metformin therapy

Angiotensin Receptor Blocker to Prevent Microalbuminuria?

Suchergebnisse filtern